• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Inland Real Estate

Inland Real Estate

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Inland Real Estate Corporation Pays December and Declares January Cash Distribution to Common Stockholders

    Inland Real Estate Corporation Pays December and Declares January Cash Distribution to Common Stockholders

  2. UNITE HERE: IL Securities Regulator Subpoenas Records from Inland American

    UNITE HERE: IL Securities Regulator Subpoenas Records from Inland American

  3. IMBRUVICA® (ibrutinib) Data Demonstrates Safety and Durability of Response at Two-Year Follow-up in Mantle Cell Lymphoma

    IMBRUVICA® (ibrutinib) Data Demonstrates Safety and Durability of Response at Two-Year Follow-up in Mantle Cell Lymphoma

  4. IMBRUVICA® (ibrutinib) Data Demonstrates Safety and Durability of Response at Two-Year Follow-up in Mantle Cell Lymphoma

    IMBRUVICA® (ibrutinib) Data Demonstrates Safety and Durability of Response at Two-Year Follow-up in Mantle Cell Lymphoma

  5. Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

    Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

  6. Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

    Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

  7. Plan Overpayment=Disaster!

    When advising an employee who is retiring, be zealous in making sure she receives everything--but not more--than she is entitled to!

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.